购物车
- 全部删除
- 您的购物车当前为空
HDGFRP2/PSIP1-IN-1 (compound BPP) 为针对HDGFRP2及PSIP1的PWWP结构域的双重抑制剂,有效阻断弥漫性内在脑桥胶质瘤 (DIPG) 的形成与进展。该化合物与HDGFRP2的结合Kd值为7 μM,配体效率为0.47;与PSIP1的PWWP结构域的结合Kd值为27 μM;对HDGFRP3的Kd值为14 μM,证实了其作为HDGFRP2PWWP亚家族抑制剂的潜力。
HDGFRP2/PSIP1-IN-1 (compound BPP) 为针对HDGFRP2及PSIP1的PWWP结构域的双重抑制剂,有效阻断弥漫性内在脑桥胶质瘤 (DIPG) 的形成与进展。该化合物与HDGFRP2的结合Kd值为7 μM,配体效率为0.47;与PSIP1的PWWP结构域的结合Kd值为27 μM;对HDGFRP3的Kd值为14 μM,证实了其作为HDGFRP2PWWP亚家族抑制剂的潜力。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | Compound BPP (HDGFRP2/PSIP1-IN-1) is a dual inhibitor targeting the PWWP domains of Hepatoma-derived Growth Factor Related Protein 2 (HDGFRP2) and its homologue PSIP1. This compound effectively hinders the occurrence and progression of Diffuse Intrinsic Pontine Glioma (DIPG). It demonstrates binding affinity with a Kd value of 7 μM for HDGFRP2, indicative of its efficient ligand efficacy at 0.47. Additionally, Compound BPP exhibits a Kd value of 27 μM when binding to the PSIP1 PWWP domain, and a Kd value of 14 μM against HDGFRP3, confirming its potency as an inhibitor within the HDGFRP2 PWWP subfamily. |
别名 | 4-(4-Bromo-1H-pyrazol-5-yl)pyridine |
分子量 | 224.06 |
分子式 | C8H6BrN3 |
CAS No. | 166196-54-9 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容